Argenica Therapeutics Ltd (AU:AGN) has released an update.
Argenica Therapeutics Limited announced the cessation of 600,000 options due to their expiry on June 10, 2024, without being exercised or converted. This financial update is relevant for investors tracking changes in the company’s issued capital.
For further insights into AU:AGN stock, check out TipRanks’ Stock Analysis page.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
